Do you know that pulmonary vascular disease is a major cause of illness in patients with congenital heart disease (CHD)? Recent advances have begun to tell us more about the way that pulmonary hypertension (PH) develops. Are you aware that the development of new drugs to treat PH in CHD has improved the outlook of patients? To learn more about pulmonary hypertension in CHD from Dr. Ian Harris, noted ACHD cardiologist, sign up for this webinar. You don’t want to miss it. Register today.
Sponsorship support provided by Actelion Pharmaceuticals US, Inc. and Gilead Sciences.